Latest filing published 20 Jul 2026 for ImageneBio, Inc., €8,012. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Robert B. Lally on record concern ImageneBio, Inc. We count 2 filings; the first trade dates from 16 July 2026 and the latest from 17 July 2026.
The open-market record consists of 2 sales worth €15k, with no purchase.
On 20 July 2026 came the latest disclosure, an open-market sale for €8,012 in ImageneBio, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations